期刊文献+

微小RNA与心房颤动关系的研究进展 被引量:5

下载PDF
导出
摘要 心房颤动(房颤)是重要的临床及公共卫生问题,现已被确定是脑卒中的独立危险因素。目前越来越多的研究表明,房颤的发生伴随着离子通道,如钠离子、钾离子、钙离子等通道的异常。因此,调控蛋白合成的细胞内机制或许能够阐明房颤的发病机制。
出处 《中华老年心脑血管病杂志》 CAS 2016年第2期208-210,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
  • 相关文献

参考文献25

  • 1Hsu SD,Lin FM,Wu WY,et al.miRTarBase:a database curates experimentally validated microRNA-target interactions.Nucleic Acids Res,2011,39:D163-D169.
  • 2Wakili R,Voigt N,Kb S,et al.Recent advances in the molecular pathophysiology of atrial fibrillation.J Clin Invest,2011,121:2955-2968.
  • 3Wolke C,Bukowska A,Goette A,et al.Redox control of cardiac remodeling in atrial fibrillation.Biochim Biophys Acta,2015,1850:1555-1565.
  • 4Nishida K,Maguy A,Sakabe M,et al.The role of pulmonary veins vs.autonomic ganglia in different experimental substrates of canine atrial fibrillation.Cardiovasc Res,2011,89:825-833.
  • 5Girmatsion Z,Biliczki P,Bonauer A,et al.Changes in micro RNA-1expression and IK1up-regulation in human atrial fibrillation.Heart Rhythm,2009,6:1802-1809.
  • 6朱瓦力,伍伟锋.心房颤动患者心房组织中微小RNA-21和金属基质蛋白酶-2表达水平改变及意义[J].中华心律失常学杂志,2011,15(2):132-135. 被引量:12
  • 7Terentyev D,Belevych AE,Terentyeva R,et al.miR-1overexpression enhances Ca(2+)release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2.Circ Res,2009,104:514-521.
  • 8Thum T,Gross C,Fiedler J,et al.MicroRNA-21contributes to myocardial disease by stimulating MAP kinase signaling in fibroblasts.Nature,2008,456:980-984.
  • 9Cardin S,Guasch E,Luo X,et al.Role for microRNA-21in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.Circ Arrhythm Electrophysiol,2012,5:1027-1035.
  • 10Adam O,Lhfelm B,Thum T,et al.Role of miR-21in the pathogenesis of atrial fibrosis.Basic Res Cardiol,2012,107:278.

二级参考文献18

  • 1柯丹,许春萱,张建成,陈林,林亚洲,林立芳,胡锡衷.心房颤动患者心房组织中明胶酶的基因表达及活性变化[J].中华心血管病杂志,2005,33(2):137-142. 被引量:26
  • 2Iwasaki YK, Nishida K, Kato T, et al. Atrial fibrillation pathophysiology: implications for management. Circulation, 2011, 124 : 2264 -2274.
  • 3Chitwood DH, Timmermans MC. Small RNAs are on the move. Nature, 2010,467:415-419.
  • 4Yang B, Lu Y, Wang Z. Control of cardiac excitability by microRNAs. Cardiovasc Res, 2008,79:571-580.
  • 5Wang JG, Li Y, Shi JH, et al. Treatment of long-lasting persistent atrial fibrillation using minimally invasive surgery combined with irbesartan. Ann Thorac Surg, 2011,91 : 1183- 1189.
  • 6Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation by miRNAs. Science, 2011,331:550-553.
  • 7Wang Z, Lu Y, Yang B. MicroRNAs and atrial fibrillation: new fundamentals. Cardiovasc Res, 2011,89:710-721.
  • 8Girmatsion Z, Biliczki P, Bonauer A, et al. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm, 2009,6 : 1802-1809.
  • 9Lu Y, Zhang Y, Wang N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation, 2010,122:2378-2387.
  • 10Shen J, Bailey MS, Damiano RJ Jr. The surgical treatment of atrial fibrillation. Heart Rhythm, 2009,6 : S45-S50.

共引文献20

同被引文献14

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部